Free Trial

P3 Health Partners (PIII) Stock Price, News & Analysis

P3 Health Partners logo
$6.72 +0.22 (+3.38%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About P3 Health Partners Stock (NASDAQ:PIII)

Key Stats

Today's Range
$6.47
$6.93
50-Day Range
$6.03
$8.45
52-Week Range
$6.00
$32.54
Volume
16,823 shs
Average Volume
19,863 shs
Market Capitalization
$47.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.25
Consensus Rating
Moderate Buy

Company Overview

P3 Health Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

PIII MarketRank™: 

P3 Health Partners scored higher than 65% of companies evaluated by MarketBeat, and ranked 377th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    P3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    P3 Health Partners has only been the subject of 1 research reports in the past 90 days.

  • Read more about P3 Health Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for P3 Health Partners are expected to grow in the coming year, from ($0.67) to ($0.37) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of P3 Health Partners is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of P3 Health Partners is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    P3 Health Partners has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about P3 Health Partners' valuation and earnings.
  • Percentage of Shares Shorted

    1.70% of the float of P3 Health Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    P3 Health Partners has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in P3 Health Partners has recently decreased by 16.35%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    P3 Health Partners does not currently pay a dividend.

  • Dividend Growth

    P3 Health Partners does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.70% of the float of P3 Health Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    P3 Health Partners has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in P3 Health Partners has recently decreased by 16.35%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    P3 Health Partners has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.95 average news sentiment score of Medical companies.
  • Insider Buying vs. Insider Selling

    In the past three months, P3 Health Partners insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.79% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.75% of the stock of P3 Health Partners is held by institutions.

  • Read more about P3 Health Partners' insider trading history.
Receive PIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

PIII Stock News Headlines

P3 Health Partners Inc. (PIII) - Yahoo Finance
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

PIII Stock Analysis - Frequently Asked Questions

P3 Health Partners' stock was trading at $11.2450 at the beginning of 2025. Since then, PIII stock has decreased by 41.0% and is now trading at $6.64.

P3 Health Partners Inc. (NASDAQ:PIII) announced its quarterly earnings results on Thursday, May, 15th. The company reported ($6.28) earnings per share for the quarter, missing analysts' consensus estimates of ($5.00) by $1.28. The firm earned $373.23 million during the quarter, compared to analyst estimates of $362.09 million. P3 Health Partners had a negative trailing twelve-month return on equity of 123.10% and a negative net margin of 9.27%.
Read the conference call transcript
.

P3 Health Partners's stock reverse split on the morning of Monday, April 14th 2025.The 1-50 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 11th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Top institutional investors of P3 Health Partners include Trinity Financial Advisors LLC (0.35%). Insiders that own company stock include Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago, Sherif Abdou and Atul Kavthekar.
View institutional ownership trends
.

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that P3 Health Partners investors own include Avino Silver & Gold Mines (ASM), PayPal (PYPL), TriNet Group (TNET), Taiwan Semiconductor Manufacturing (TSM), XPeng (XPEV), 3M (MMM) and nCino (NCNO).

Company Calendar

Last Earnings
5/15/2025
Today
7/17/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PIII
CIK
1832511
Fax
N/A
Employees
500
Year Founded
N/A

Price Target and Rating

High Price Target
$20.00
Low Price Target
$12.50
Potential Upside/Downside
+144.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($47.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$135.85 million
Net Margins
-9.27%
Pretax Margin
-20.31%
Return on Equity
-123.10%
Return on Assets
-15.94%

Debt

Debt-to-Equity Ratio
1.68
Current Ratio
0.38
Quick Ratio
0.38

Sales & Book Value

Annual Sales
$1.49 billion
Price / Sales
0.03
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.58 per share
Price / Book
0.63

Miscellaneous

Outstanding Shares
7,188,000
Free Float
5,909,000
Market Cap
$47.73 million
Optionable
Not Optionable
Beta
0.78
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:PIII) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners